Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).

被引：30

作者：

Iveson, Timothy

Sobrero, Alberto F.

Yoshino, Takayuki

Sougklakos, Ioannis

Ou, Fang-Shu

Meyers, Jeffery P.

Shi, Qian

Saunders, Mark P.

Labianca, Roberto

Yamanaka, Takeharu

Boukovinas, Ioannis

Hollander, Niels Henrik

Torri, Valter

Yamazaki, Kentaro

Georgoulias, Vassilis

Lonardi, Sara

Harkin, Andrea

Rosati, Gerardo

Paul, James

机构：

[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England

[2] IRCCS Osped San Martino IST, Genoa, Italy

[3] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[4] Univ Heraklion, Iraklion, Greece

[5] Mayo Clin, Rochester, MN USA

[6] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA

[7] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA

[8] Christie NHS Fdn Trust, Manchester, Lancs, England

[9] Osped Papa Giovanni XXIII, Bergamo, Italy

[10] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan

[11] Bioclin Thessaloniki Med Oncol Unit, Athens, Greece

[12] Sygehus Syd Naestved, Naestved, Denmark

[13] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy

[14] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[15] Univ Crete, Tumor Cell Biol Lab, Sch Med, Athens, AZ, Greece

[16] Ist Oncol Veneto IRCCS, Padua, Italy

[17] CRUK, Glasgow, Lanark, Scotland

[18] San Carlo Hosp, Med Oncol Unit, Potenza, Italy

[19] Univ Glasgow, Canc Res UK Clin Trials Unit, Inst Canc Res, Glasgow, Lanark, Scotland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.3501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3501

引用

页数：2